CHAMPIONS ONCOLOGY, INC. Operating Lease Right-of-Use Assets
CHAMPIONS ONCOLOGY, INC. (CSBR) had Operating Lease Right-of-Use Assets of $9.68 million as of 2026-07-31, per its 10-Q filed 2026-09-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:OperatingLeaseRightOfUseAsset · last filed 2026-09-11
- 2026-07-31: Operating Lease, Right-of-Use Asset $9.68M.
- 2026-04-30: Operating Lease, Right-of-Use Asset $3.70M.
- 2026-01-31: Operating Lease, Right-of-Use Asset $4.03M.
- 2025-10-31: Operating Lease, Right-of-Use Asset $4.35M.
| Period end | Operating Lease, Right-of-Use Asset | Operating Lease, Right-of-Use Asset as first filed |
|---|---|---|
| 2026-07-31 | $9.68M 10-Q · filed 2026-09-11 | |
| 2026-04-30 | $3.70M 10-Q · filed 2026-09-11 | |
| 2026-01-31 | $4.03M 10-Q · filed 2026-03-12 | |
| 2025-10-31 | $4.35M 10-Q · filed 2025-12-15 | |
| 2025-07-31 | $4.77M 10-Q · filed 2025-09-15 | |
| 2025-04-30 | $5.08M 10-K · filed 2026-07-27 | |
| 2025-01-31 | $5.37M 10-Q · filed 2025-03-17 | |
| 2024-10-31 | $5.67M 10-Q · filed 2024-12-16 | |
| 2024-07-31 | $5.96M 10-Q · filed 2024-09-13 | |
| 2024-04-30 | $6.25M 10-K · filed 2025-07-23 | |
| 2024-01-31 | $6.54M 10-Q · filed 2024-03-15 | |
| 2023-10-31 | $6.82M 10-Q · filed 2023-12-13 | |
| 2023-07-31 | $7.09M 10-Q · filed 2023-09-13 | |
| 2023-04-30 | $7.32M 10-K · filed 2024-07-19 | |
| 2023-01-31 | $7.59M 10-Q · filed 2023-03-16 | |
| 2022-10-31 | $7.70M 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $7.97M 10-Q · filed 2022-09-12 | |
| 2022-04-30 | $8.23M 10-K · filed 2023-07-24 | |
| 2022-01-31 | $8.42M 10-Q · filed 2022-03-15 | |
| 2021-10-31 | $8.26M 10-Q · filed 2021-12-13 | |
| 2021-07-31 | $8.33M 10-Q · filed 2021-09-13 | |
| 2021-04-30 | $8.52M 10-K · filed 2022-07-22 | |
| 2021-01-31 | $5.38M 10-Q · filed 2021-03-15 | |
| 2020-10-31 | $5.53M 10-Q · filed 2020-12-14 | |
| 2020-07-31 | $5.67M 10-Q · filed 2020-09-14 | |
| 2020-05-01 | $8.52M 10-K · filed 2022-07-22 | $2.80M 10-K · filed 2021-07-26 |
| 2020-04-30 | $2.80M 10-K · filed 2021-07-26 | |
| 2020-01-31 | $2.90M 10-Q · filed 2020-03-16 | |
| 2019-10-31 | $3.00M 10-Q · filed 2019-12-16 | |
| 2019-07-31 | $3.10M 10-Q · filed 2020-09-14 | |
| 2019-05-01 | $3.20M 10-K · filed 2020-07-28 | $3.20M 10-K · filed 2019-07-29 |
| 2019-04-30 | $0.00 10-Q · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |